$ARCT
Arcturus Therapeutics Holdings Inc.

2020 Q1 Form 10-K Financial Statement

#000156459020011037 Filed on March 16, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2018 Q4 2018
Revenue $2.646M $7.580M $15.75M
YoY Change -39.17% 275.25% 21.18%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.190M $3.440M $20.58M
YoY Change 18.7% 30.8% 171.86%
% of Gross Profit
Research & Development $7.917M $4.850M $16.98M
YoY Change 8.1% 11.49% 6.67%
% of Gross Profit
Depreciation & Amortization $180.0K $160.0K $580.0K
YoY Change 5.88% 45.45% 41.46%
% of Gross Profit
Operating Expenses $12.11M $8.290M $37.56M
YoY Change 11.51% 18.6% 59.91%
Operating Profit -$9.462M -$21.81M
YoY Change 45.39%
Interest Expense -$320.0K -$300.0K $30.00K
YoY Change -15.79% -850.0% -150.0%
% of Operating Profit
Other Income/Expense, Net -$152.0K $328.0K
YoY Change 72.73% -193.71%
Pretax Income -$9.780M -$1.010M -$21.60M
YoY Change 42.15% -80.87% 98.2%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$9.777M -$1.010M -$21.79M
YoY Change 42.02% -80.87% 99.86%
Net Earnings / Revenue -369.5% -13.32% -138.29%
Basic Earnings Per Share
Diluted Earnings Per Share -$673.6K -$100.0K -$2.164M
COMMON SHARES
Basic Shares Outstanding 15.14M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2018 Q4 2018
SHORT-TERM ASSETS
Cash & Short-Term Investments $59.50M $36.70M $36.70M
YoY Change 90.71% -24.49% -24.49%
Cash & Equivalents $59.47M $36.71M $36.70M
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $593.0K $92.00K $600.0K
YoY Change -34.11% -95.16% -66.67%
Inventory
Prepaid Expenses $1.344M $546.0K
Receivables $2.351M $4.481M $4.500M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $63.76M $41.83M $41.80M
YoY Change 74.2% -17.82% -17.88%
LONG-TERM ASSETS
Property, Plant & Equipment $2.571M $1.975M $2.000M
YoY Change -66.61% 97.5% 100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $100.0K $288.0K $300.0K
YoY Change
Other Assets $100.0K $100.0K $100.0K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $8.345M $2.370M $2.400M
YoY Change 6.99% 115.45% 118.18%
TOTAL ASSETS
Total Short-Term Assets $63.76M $41.83M $41.80M
Total Long-Term Assets $8.345M $2.370M $2.400M
Total Assets $72.10M $44.20M $44.20M
YoY Change 62.4% -15.0% -15.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.779M $2.398M $2.400M
YoY Change -7.83% 33.22% 33.33%
Accrued Expenses $9.775M $3.907M $3.900M
YoY Change 443.06% 39.54% 116.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $21.65M $12.58M $12.60M
YoY Change 48.29% 14.34% 14.55%
LONG-TERM LIABILITIES
Long-Term Debt $15.03M $9.911M $9.900M
YoY Change 51.8%
Other Long-Term Liabilities $18.40M $8.100M $8.100M
YoY Change 36.3% 12.5% 12.5%
Total Long-Term Liabilities $15.03M $9.911M $18.00M
YoY Change -35.78% 37.65% 150.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $21.65M $12.58M $12.60M
Total Long-Term Liabilities $15.03M $9.911M $18.00M
Total Liabilities $55.12M $30.56M $30.60M
YoY Change 44.68% 67.89% 68.13%
SHAREHOLDERS EQUITY
Retained Earnings -$81.45M -$44.87M
YoY Change
Common Stock $15.00K $214.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $16.98M $13.64M $13.60M
YoY Change
Total Liabilities & Shareholders Equity $72.10M $44.20M $44.20M
YoY Change 62.4% -15.0% -15.0%

Cashflow Statement

Concept 2020 Q1 2018 Q4 2018
OPERATING ACTIVITIES
Net Income -$9.777M -$1.010M -$21.79M
YoY Change 42.02% -80.87% 99.86%
Depreciation, Depletion And Amortization $180.0K $160.0K $580.0K
YoY Change 5.88% 45.45% 41.46%
Cash From Operating Activities -$11.86M -$5.760M -$20.76M
YoY Change 119.15% -215.2% 4413.04%
INVESTING ACTIVITIES
Capital Expenditures $142.0K -$230.0K $1.478M
YoY Change 82.05% 53.33% -691.2%
Acquisitions
YoY Change
Other Investing Activities $2.490M $23.61M
YoY Change -76.53% 122.53%
Cash From Investing Activities -$142.0K $2.260M $22.13M
YoY Change 82.05% -78.39% 113.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 118.0K 9.870M 10.20M
YoY Change 831.13% 45.77%
NET CHANGE
Cash From Operating Activities -11.86M -5.760M -20.76M
Cash From Investing Activities -142.0K 2.260M 22.13M
Cash From Financing Activities 118.0K 9.870M 10.20M
Net Change In Cash -11.88M 6.370M 11.58M
YoY Change 116.47% -61.44% -31.49%
FREE CASH FLOW
Cash From Operating Activities -$11.86M -$5.760M -$20.76M
Capital Expenditures $142.0K -$230.0K $1.478M
Free Cash Flow -$12.00M -$5.530M -$22.24M
YoY Change 118.62% -207.38% 10489.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
400000
CY2019Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Entity Registrant Name
EntityRegistrantName
ARCTURUS THERAPEUTICS HOLDINGS INC.
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001768224
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2019 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20582000
CY2018 us-gaap Operating Expenses
OperatingExpenses
37564000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12662000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33640000
CY2019 us-gaap Operating Expenses
OperatingExpenses
46302000
CY2019 dei Entity File Number
EntityFileNumber
001-38942
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-446000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
328000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-21785000
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
15545000
CY2019 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2019 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
32-0595345
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4481000
CY2019Q4 arct Prepaid Expenses And Other Receivables
PrepaidExpensesAndOtherReceivables
758000
CY2018Q4 arct Prepaid Expenses And Other Receivables
PrepaidExpensesAndOtherReceivables
638000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
74290000
CY2019Q2 dei Entity Public Float
EntityPublicFloat
76400000
CY2019 dei Document Transition Report
DocumentTransitionReport
false
CY2019 dei Document Annual Report
DocumentAnnualReport
true
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71353000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36709000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2179000
CY2019 dei Entity Address Address Line1
EntityAddressAddressLine1
10628 Science Center Drive
CY2019 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 250
CY2019 dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2019 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92121
CY2019 dei City Area Code
CityAreaCode
858
CY2019 dei Local Phone Number
LocalPhoneNumber
900-2660
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15137964
CY2018Q4 us-gaap Assets Current
AssetsCurrent
41828000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2349000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1975000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5134000
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
263000
CY2018Q4 us-gaap Equity Method Investments
EquityMethodInvestments
288000
CY2019Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
107000
CY2018Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
107000
CY2019Q4 us-gaap Assets
Assets
82143000
CY2018Q4 us-gaap Assets
Assets
44198000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5793000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2398000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7134000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3907000
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
8397000
CY2018Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6272000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
21324000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12577000
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
15182000
CY2018Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
7534000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
14995000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
9911000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4850000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
534000
CY2019Q4 us-gaap Liabilities
Liabilities
56351000
CY2018Q4 us-gaap Liabilities
Liabilities
30556000
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019 arct Contract With Customer Asset Deductions For Cash Collections
ContractWithCustomerAssetDeductionsForCashCollections
-19824000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.07
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15138000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15138000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20789000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15753000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16982000
CY2018 us-gaap Dividends
Dividends
0
CY2018Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
4480000
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
13806000
CY2019 arct Contract With Customer Liability Additions For Advanced Billings
ContractWithCustomerLiabilityAdditionsForAdvancedBillings
30134000
CY2019 us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
803000
CY2019 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-21164000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
23579000
CY2018Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
43000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10762000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10719000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-25513000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-21811000
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-32000
CY2018 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-302000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-25991000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.15
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.16
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12069000
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10069000
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25991000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21782000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
33794000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1259000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
371000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1982000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
21278000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
139000
CY2019 us-gaap Cumulative Effect On Retained Earnings Tax1
CumulativeEffectOnRetainedEarningsTax1
-803000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
684000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
582000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
1982000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
1259000
CY2019 arct Loss From Equity Method Investments
LossFromEquityMethodInvestments
25000
CY2018 arct Loss From Equity Method Investments
LossFromEquityMethodInvestments
302000
CY2019 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-873000
CY2018 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-38000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2302000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4001000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
120000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-421000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3155000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
578000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1675000
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1687000
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
8970000
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
159000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6445000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20760000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
818000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1478000
CY2018 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
6594000
CY2018 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
30206000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-818000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
22134000
CY2019 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
4945000
CY2018 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
9872000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
139000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
332000
CY2019 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
15545000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
21278000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
41907000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10204000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25238000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
34644000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11578000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36816000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71460000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
691000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
146000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5868000
CY2018 arct Sale Of Intangible Assets For Equity Method Investment
SaleOfIntangibleAssetsForEquityMethodInvestment
590000
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
240000
CY2018 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
30000
CY2018 arct Release Of Repurchase Liability For Restricted Shares
ReleaseOfRepurchaseLiabilityForRestrictedShares
39000
CY2019 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 13. Litigation</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;;font-weight:normal;font-style:normal;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">On December 13, 2019, a former employee of the Company filed a complaint in San Diego County Superior Court, captioned Adonary Munoz v. Arcturus Therapeutics, Inc., et al, Case No. 37-2019-00066358-CU-PO-CTL. The lawsuit alleges sexual assault by an acquaintance of one of our employees and seeks to hold the Company liable on a number of causes of action. On January 17, 2020, a second amended complaint (&#8220;SAC&#8221;) was filed seeking $30 million in damages, including punitive damages and damages for emotional distress. The Company is required to file a response to the SAC by March 20, 2020. The Company believes the allegations of Ms. Munoz in her complaint are without merit, and intends to vigorously defend itself in the foregoing action. However, in light of the preliminary stage of the litigation, the Company is unable to estimate a potential loss or range of losses relating to this matter.</p>
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentration of Credit Risk and Significant Customers</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents. The Company limits its exposure to credit loss by placing its cash and cash equivalents with high credit quality financial institutions in instruments with short maturities. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There was one customer that comprised 98% of the total accounts receivable balance at December 31, 2019 and one customer that comprised 96% of the total accounts receivable balance at December 31, 2018. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the year ended December 31, 2019, the Company&#8217;s top four customers<font style="color:#000000;"> collectively </font>represented 91% of the Company&#8217;s total revenue. For the year ended December 31, 2018, there were three customers that collectively represented 80% of the Company&#8217;s total revenue. </p>
CY2019 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
one-for-one
CY2019Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
1
CY2019Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
21400000
CY2019 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019 arct Lease Expiration Year
LeaseExpirationYear
2025
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2019Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.30
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2018 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2018 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0
CY2019 us-gaap Dividends
Dividends
0
CY2019 arct Contract With Customer Asset Additions For Revenue Recognized
ContractWithCustomerAssetAdditionsForRevenueRecognized
17523000
CY2019Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
2179000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1608000
CY2019 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
974000
CY2019Q4 arct Accrued Cystic Fibrosis Foundation Liability
AccruedCysticFibrosisFoundationLiability
1949000
CY2018Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
2259000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
827000
CY2019Q4 arct Other Accrued Research And Development Expenses
OtherAccruedResearchAndDevelopmentExpenses
2750000
CY2018Q4 arct Other Accrued Research And Development Expenses
OtherAccruedResearchAndDevelopmentExpenses
674000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4530000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3472000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2181000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1497000
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
4000000
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
6000000
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
5450000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
15450000
CY2019 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
900000
CY2018 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
200000
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
138377
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
94000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1184433
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
590115
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
24290
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
101182
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1649076
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
581135
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1649076
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.41
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.81
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.72
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
8.01
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.54
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.03
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
7.54
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y7M2D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y8M4D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P8Y7M2D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5498000
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2236000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
5498000
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5800000
CY2019 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M12D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1900000
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1000000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1982000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1259000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-25922000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-21604000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-69000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-181000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-25991000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-21785000
CY2018Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2019 arct Maximum Percentage Of Likelihood Of Uncertain Tax Position Recognized To Be Sustained
MaximumPercentageOfLikelihoodOfUncertainTaxPositionRecognizedToBeSustained
0.50
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
400000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
400000
CY2018 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
15078000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8399000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
28000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
35000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
410000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
261000
CY2019Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
1248000
CY2018Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
1713000
CY2019Q4 arct Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
1466000
CY2018Q4 arct Deferred Tax Assets Property Plant And Equipment And Intangible Assets
DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets
46000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
339000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
85000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
18569000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
10539000
CY2019Q4 arct Deferred Tax Liabilities Property Plant And Equipment And Intangible Assets
DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndIntangibleAssets
11000
CY2018Q4 arct Deferred Tax Liabilities Property Plant And Equipment And Intangible Assets
DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndIntangibleAssets
0
CY2019Q4 arct Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
1326000
CY2018Q4 arct Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
0
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
17232000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10539000
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2019 arct Net Operating Loss And Research And Development Credit Carryforwards Limitations On Cumulative Change In Ownership Minimum Percentage
NetOperatingLossAndResearchAndDevelopmentCreditCarryforwardsLimitationsOnCumulativeChangeInOwnershipMinimumPercentage
0.50
CY2019 arct Net Operating Loss And Research And Development Credit Carryforwards Limitations On Cumulative Change In Ownership Period
NetOperatingLossAndResearchAndDevelopmentCreditCarryforwardsLimitationsOnCumulativeChangeInOwnershipPeriod
P3Y
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.046
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.053
CY2019 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.003
CY2018 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.013
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.001
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.002
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.001
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.251
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.207
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
0.001
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
-0.030
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.007
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.011
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1272000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1310000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1349000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1390000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1432000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
314000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
7067000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1390000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
5677000
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y3M
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.084
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
1200000
CY2018 us-gaap Operating Lease Cost
OperatingLeaseCost
1100000

Files In Submission

Name View Source Status
0001564590-20-011037-index-headers.html Edgar Link pending
0001564590-20-011037-index.html Edgar Link pending
0001564590-20-011037.txt Edgar Link pending
0001564590-20-011037-xbrl.zip Edgar Link pending
arct-10k_20191231.htm Edgar Link pending
arct-20191231.xml Edgar Link completed
arct-20191231.xsd Edgar Link pending
arct-20191231_cal.xml Edgar Link unprocessable
arct-20191231_def.xml Edgar Link unprocessable
arct-20191231_lab.xml Edgar Link unprocessable
arct-20191231_pre.xml Edgar Link unprocessable
arct-ex101_364.htm Edgar Link pending
arct-ex1023_426.htm Edgar Link pending
arct-ex1024_365.htm Edgar Link pending
arct-ex231_11.htm Edgar Link pending
arct-ex311_9.htm Edgar Link pending
arct-ex312_16.htm Edgar Link pending
arct-ex313_7.htm Edgar Link pending
arct-ex321_6.htm Edgar Link pending
arct-ex322_10.htm Edgar Link pending
arct-ex323_14.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gztpitn4150m000001.jpg Edgar Link pending
gztpitn4150m000002.jpg Edgar Link pending
gztpitn4150m000003.jpg Edgar Link pending
gztpitn4150m000004.jpg Edgar Link pending
gztpitn4150m000005.jpg Edgar Link pending
gztpitn4150m000006.jpg Edgar Link pending
gztpitn4150m000007.jpg Edgar Link pending
gztpitn4150m000008.jpg Edgar Link pending
gztpitn4150m000009.jpg Edgar Link pending
gztpitn4150m000010.jpg Edgar Link pending
gztpitn4150m000011.jpg Edgar Link pending
gztpitn4150m000012.jpg Edgar Link pending
gztpitn4150m000013.jpg Edgar Link pending
gztpitn4150m000014.jpg Edgar Link pending
gztpitn4150m000015.jpg Edgar Link pending
gztpitn4150m000016.jpg Edgar Link pending
gztpitn4150m000017.jpg Edgar Link pending
gztpitn4150m000018.jpg Edgar Link pending
gztpitn4150m000019.jpg Edgar Link pending
gztpitn4150m000020.jpg Edgar Link pending
gztpitn4150m000021.jpg Edgar Link pending
gztpitn4150m000022.jpg Edgar Link pending
gztpitn4150m000023.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending